logo
Grieving parents want better access to mental health records

Grieving parents want better access to mental health records

Yahoo18 hours ago
Doctors should legally be able to tell parents if their child is struggling with their mental health, the parents of a teenager who took her own life have said.
Jessica Glasser died in May. Her parents Mary and David feel they could have helped her more if they had known "what she told the GP behind closed doors".
Jessica was 17 years old when she first spoke to a GP in December 2024.
The Royal College of General Practitioners (RCGP) in Northern Ireland has said all doctors must work within legal and ethical frameworks and respect patient confidentiality.
"Something needs to change regarding the age of disclosure," Mrs Glasser told BBC News NI.
In Northern Ireland, individuals aged 16 and over are presumed to have the capacity to consent to medical treatment and the disclosure of their medical information, according to the General Medical Council (GMC).
For those under 16, capacity to consent to disclosure is assessed on a case-by-case basis, and if lacking, parental consent can be sought.
Jessica, who wanted to be a vet, turned 18 in January.
Her parents said they only found out about the severity of her mental health struggles from her GP after her death.
"We are in pain every single day," Mrs Glasser said.
"She was our bright beautiful star."
"Not enough is being done to help young people here. There should be more engagement with parents, the GP and mental health practitioners, even when your child is 18 or over."
The RCGP said the doctor-patient relationship depended on confidentiality.
"Doctors can only share information with family members when a patient, who has capacity, has given their consent," it added.
Jessica's parents told BBC News NI she had struggled after being bullied at a young age.
"The earlier bullying stayed with her throughout the years," Mr Glasser said.
"She kept all her burdens to herself because she didn't want to hurt us.
"She was just a wonderful kid and was hard working. For her to be gone is just soul destroying.
"The fact she isn't here to fulfil her dreams is heartbreaking."
Jessica had a consultation about her mental health in December 2024 but an appointment in January 2025 was cancelled due to unplanned leave by the mental health practitioner.
Her parents are angry the appointment was not rescheduled.
"This should never have happened," said Mrs Glasser.
"Lessons need to be learned here."
The practice Jessica attended told BBC News NI it was "unable to comment due to patient confidentiality" but expressed its deepest sympathies to the family for their loss.
Her parents have also called for the full implementation of the Department of Health's Mental Health Strategy.
"Our politicians really need to fight more for our young people," Mrs Glasser added.
"How is this strategy not fully implemented yet?"
The 10-year mental health strategy was published in June 2021, with £1.2bn needed to fully implement its recommendations.
A Department of Health spokesperson said mental health was a key area of focus for the minister and that he wished to convey his deepest sympathy to the Glassers.
"Northern Ireland has historically had higher prevalence rates of mental ill-health compared to other regions across the United Kingdom," they added.
"Despite higher need, however, funding levels for services here have been lower."
To date, the department said no additional funding had been provided to support the implementation of the strategy.
"The minister will continue to press the case for sustained additional funding," the department added.
Mrs Glasser has called on parents to talk to their children if they have any concerns.
"Never assume they are fine," she said.
"Jessica didn't always open up because she cared and didn't want us worrying, but talking is key.
"No parent should ever have to deal with this. We want to help other parents."
For information and support about any issues raised in this story contact the BBC Action Line.
Pupils train as 'wellbeing prefects' to provide support for peers
Mental health nurses on 999 calls reduce ED admissions
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Plexāā Closes $4.5 Million Funding Extension to Drive U.S. Launch of BLOOM43 Platform for Breast Surgery
Plexāā Closes $4.5 Million Funding Extension to Drive U.S. Launch of BLOOM43 Platform for Breast Surgery

Associated Press

time2 hours ago

  • Associated Press

Plexāā Closes $4.5 Million Funding Extension to Drive U.S. Launch of BLOOM43 Platform for Breast Surgery

LONDON--(BUSINESS WIRE)--Jul 8, 2025-- Plexāā, a MedTech startup behind the award-winning BLOOM 43 medical device for breast surgery, has announced the close of a $4.5 million funding extension round. The strategic capital infusion will support the imminent U.S. launch of BLOOM 43, while also laying the groundwork for future innovations. The funding also strengthens the company's position ahead of their planned Series A fundraising round. Complication rates in breast surgeries, which can include infection, skin necrosis and the need for additional surgeries, have been recorded as high as 30 percent. 1 BLOOM 43 is the world's first fully wearable medical device designed to help patients prepare for breast cancer surgery and reconstruction by harnessing the power of Supraphysiological Preconditioning ™. The new technique safely and intermittently thermally preconditions the skin causing the release of heat-shock proteins that cause vasodilation and increased blood flow to the area. This process has been shown to reduce wound healing complications in proof-of-concept clinical trials. Along with its BLOOM 43 companion app, the device has demonstrated substantial improvements in the patient experience and surgical readiness, harnessing the power of holistic Prehabilitation ™ and preconditioning. The company has already secured multiple partners for its upcoming U.S. commercial launch. 'I want to thank our team for the tremendous progress it has made to make this financing possible,' said Dr. Saahil Mehta, founder and CEO of Plexāā. 'Securing this funding validates confidence in our flagship technology and the concept of Supraphysiological Preconditioning ™, and it energizes the team as we prepare to bring BLOOM 43 to a wider patient population in the U.S. and beyond. The funds will support this pivotal launch and market expansion, as well as the exciting development of our technology platform – including devices and apps targeting additional surgical specialties and creating a whole new category in surgery.' Plexāā Ltd has been backed by TCP Health Ventures (the dedicated healthcare investment arm of The Capital Partnership group of companies) who led the Seed Round. This extension round comprises existing and new investors including TCP. Further investment includes over $1.6 million in i4i grant funding from the National Institute for Health and Care Research (NIHR), and $1.3 million from Thena Capital, a London-based VC firm backed by the British Business Bank and focused on digital health and fast-tracked Medtech. Tatum Getty, founding General Partner at THENA Capital added, 'Since 2023, we've been closely tracking Plexāā's progress and the development of its first device, BLOOM 43. We couldn't be more excited for Plexāā to become our first portfolio company for THENA Capital's Fund I. The company is solving a critical and under-addressed challenge across the surgical pathway- reducing post-operative complications for patients which also addresses the impact to both providers and payers. 'Saahil and his team bring together clinical, engineering, and operational expertise from some of the UK's leading institutions. Their bold ambition to scale globally, beginning with an imminent commercial launch in the U.S., is exactly the kind of UK MedTech leadership team we look to champion. Our fund's commercialisation support model is well-suited to help Plexāā expand into women's health and adjacent categories where better outcomes and patient experiences are urgently needed.' Plexāā plans to collaborate with clinicians, patients, and partners worldwide to make prehabilitation and preconditioning the standard of care for surgery — and to deliver transformative solutions that address unmet needs in surgical care. About Plexāā Plexāā is a pioneering UK-based MedTech company focused on improving surgical outcomes through devices and digital products. Its flagship device, BLOOM 43, enables patients to supraphysiologically precondition their skin, potentially reducing the risk of wound healing complications such as infection and skin necrosis, which affect one in three women undergoing breast surgery. Plexāā is also exploring the application of this technology in other surgical fields, including obstetrics for C-sections, orthopaedics for joint operations, and general and vascular surgery, with a commitment to improving pre-operative preparation for surgery and patient outcomes. About TCP Health Ventures TCP Health Ventures is the dedicated healthcare investment arm of The Capital Partnership group of companies, a multi-asset investment company with assets under management of $7 billion. Headquartered out of London, TCP Health Ventures manages assets of $ 225 million across 15+ investments in the med-tech space and has a med-tech investing experience of 10 years. About the NIHR The mission of the National Institute for Health and Care Research (NIHR) is to improve the health and wealth of the nation through research. We do this by: NIHR is funded by the Department of Health and Social Care. Its work in low- and middle- income countries is principally funded through UK international development funding from the UK government. About THENA Capital THENA Capital is a London-based venture capital firm backing the world's next category-defining medical technologies. We invest in breakthrough companies transforming care experiences through digital health, fast-tracked medical devices, and clinical-grade innovation. THENA's debut Fund 1, focuses on high-impact, UK-founded technologies addressing unmet needs across women's health, oncology, cardiovascular disease, chronic conditions, and care delivery. With deep clinical, regulatory and operational expertise, THENA Capital partners with founders to unlock international scale, navigate complex markets, and build enduring category leaders in global healthcare. References 1 Annals of Translational Medicine, Dec 2023, Management of complications following implant-based breast reconstruction: a narrative review, Dean H. Meshkin 1^, Joseph M. Firriolo 1, Nolan S. Karp 2, Ara A. Salibian 1 View source version on CONTACT: Media Contacts: Sam Choinski Pazanga Health Communications [email protected] (860) 301-5058 [email protected] KEYWORD: EUROPE UNITED STATES UNITED KINGDOM NORTH AMERICA NEW YORK INDUSTRY KEYWORD: TECHNOLOGY BIOTECHNOLOGY HEALTH CONSUMER APPS/APPLICATIONS SURGERY PROFESSIONAL SERVICES ONCOLOGY MEDICAL DEVICES SOFTWARE DATA ANALYTICS HEALTH TECHNOLOGY WOMEN DATA MANAGEMENT SOURCE: Plexāā Copyright Business Wire 2025. PUB: 07/08/2025 03:46 PM/DISC: 07/08/2025 03:46 PM

Little Man Syndrome: What Is It and How Can It Be Harmful?
Little Man Syndrome: What Is It and How Can It Be Harmful?

Health Line

time3 hours ago

  • Health Line

Little Man Syndrome: What Is It and How Can It Be Harmful?

Little man syndrome refers to the idea that shorter men are more likely to display overly aggressive or dominant behavior in order to overcompensate for their height. This term is based on a social stereotype and is not a medical diagnosis. Little man syndrome, also known as the Napoleon Complex, is the idea that shorter men may feel inferior due to their height and use aggressive or dominant behavior to compensate. However, this is not a real syndrome or medical diagnosis. Instead, it is based on a problematic social stereotype that can lead to negative mental health effects such as social anxiety, depression, and low self-esteem. It's important to remember that human behavior extends far beyond our physical appearance and can be influenced by many factors such as our lived experiences, cultural norms, and social environment. What is little man syndrome? Little man syndrome is often attributed to the French dictator Napoleon Bonaparte, stemming from the myth that he used aggressive leadership to compensate for his short height. In popular culture, the stereotype is used to describe someone who has an ' inferiority complex ' due to their height, which manifests in behaviors that are controlling, overly dominant, or aggressive. In some instances, it is also used to refer to men of any height who prioritize the need to be right over accepting new ideas or opinions. In other words, someone who is small or narrow-minded. How can it affect men's mental health? Even without aggressive or dominant behavior, the stereotype of little man syndrome can be damaging and negatively affect mental health. This is because it reinforces the toxic idea that shorter men should feel inadequate and that masculinity is about dominance and is linked to height and intimidation. It can lead to negative body image, which can worsen existing mental health conditions or trigger new ones. In fact, a 2025 review found that body image concerns in men can often lead to the development of: low self-esteem depression anxiety Calling out harmful behavior Let's be clear: A stereotype cannot be used to dismiss or justify abuse. Controlling, toxic, or aggressive behavior is the real issue here, not a person's appearance. While someone may feel insecure in a relationship, it is not ok if they: are aggressive, verbally or physically display unhealthy jealousy isolate you from friends or family are overly possessive use guilt to manipulate you Remember, someone may feel insecure about their self-image, but that is never an excuse for harmful or abusive behavior. It is not your responsibility to carry the weight of their emotions. The following organizations offer tools and resources to support people experiencing abuse: National Domestic Violence Hotline: Call 800-799-7233 24 hours a day, 7 days a week for support. StrongHearts Native Helpline: Call 844-762-8483 or chat with an advocate on the website. National Deaf Domestic Violence Hotline: Call 855-812-1001 or text START to 88788. Immigrant Legal Resource Center: Support and advocacy search tool for non-U.S. citizens. Why we need to challenge toxic masculinity Toxic masculinity can often promote damaging ideas about what it is to 'be a man.' It can lead to behaviors that are harmful to the individual as well as others. This includes: suppressing emotions and instead feeling as though you have to 'toughen up' exerting dominance in all areas of your life, including work and romantic relationships being overly competitive refusing to do tasks that are traditionally deemed 'feminine,' such as household work using intimidation, aggression, or violence as a way to maintain control It can sometimes lead to men feeling pressured into displaying the above harmful behaviors in order to be perceived as masculine or 'man enough.' Challenging these stereotypes and behaviors when possible and safe to do so can help increase emotional awareness around toxic masculinity and break down harmful societal expectations. The bottom line Little man syndrome, also known as the Napoleon Complex, is the idea that shorter men may feel inferior due to their height and use aggressive or dominant behavior to compensate. Even without aggressive or dominant behavior, the stereotype of little man syndrome can be damaging and negatively affect mental health. It can lead to symptoms such as social anxiety, depression, and low self-esteem.

Transforming Healthcare Ltd Launches the Healthcare Convergence Framework: A Pioneering AI/Robotics Readiness Assessment Tool for Healthcare
Transforming Healthcare Ltd Launches the Healthcare Convergence Framework: A Pioneering AI/Robotics Readiness Assessment Tool for Healthcare

Associated Press

time4 hours ago

  • Associated Press

Transforming Healthcare Ltd Launches the Healthcare Convergence Framework: A Pioneering AI/Robotics Readiness Assessment Tool for Healthcare

London, UK , July 08, 2025 (GLOBE NEWSWIRE) -- Transforming Healthcare Ltd, a leader in healthcare consultancy and innovation, has announced the global launch of the Healthcare Convergence Framework® (HCF), the world's first AI/Robotics Readiness Assessment Tool specifically designed for healthcare organisations. Developed by the esteemed physician and thriving healthcare strategist Dr. Pietro Emanuele Garbelli, this groundbreaking framework is set to revolutionise the way hospitals, clinicians, and decision-makers evaluate their preparedness for integrating artificial intelligence and robotics into patient care, governance, and clinical operations. The Healthcare Convergence Framework® AI/Robotics Assessment tool arrives at a pivotal moment in the healthcare industry, where the acceleration of AI technologies demands strategic, clinician-led implementation. This tool empowers healthcare organisations to assess their readiness while safeguarding the ethics, trust, and human essence of medicine. By providing a comprehensive evaluation, the HCF ensures that healthcare providers can navigate the complexities of AI integration with confidence and foresight. 'The launch of the Healthcare Convergence Framework® marks a significant milestone in our mission to enhance care quality and reduce systemic inefficiencies,' said Dr. Pietro Emanuele Garbelli, CEO of Transforming Healthcare Ltd. 'This tool is not just about technology readiness; it's about ensuring that the integration of AI and robotics is done ethically and with a focus on maintaining the human touch in medicine.' The tool is now publicly accessible via providing healthcare leaders and decision makers with an invaluable resource to guide their strategic planning and operational readiness. As AI continues to transform the healthcare landscape, the HCF offers a structured approach to embracing these advancements responsibly and effectively. Transforming Healthcare Ltd, founded by Dr. Garbelli, is dedicated to shaping intelligent, ethical, and future-ready healthcare systems. Through strategic frameworks like the Healthcare Convergence Framework® and high-impact advisory, the company empowers healthcare organisations, clinicians, and healthcare leaders and decision-makers to lead with clinical excellence in the digital age. Dr Pietro Emanuele Garbelli About Transforming Healthcare Ltd Transforming Healthcare Ltd is a forward-thinking consultancy and innovation company dedicated to shaping intelligent, ethical, and future-ready healthcare systems. Founded by Dr. Pietro Emanuele Garbelli, the company empowers hospitals, clinicians, and healthcare leaders to navigate the evolving intersection of medicine, AI, and robotics. Through strategic frameworks, like the Healthcare Convergence Framework®, and high-impact advisory, Transforming Healthcare Ltd helps organisations enhance care quality, reduce systemic inefficiencies, and lead with clinical excellence in the digital age. Press inquiries Transforming Healthcare Ltd Pietro Emanuele Garbelli [email protected] 07517463999 20-22 Wenlock Road London N1 7GU United Kingdom

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store